Endurant Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-3,674
| Closed | -$618K | – | 63 |
|
|
2018
Q3 | $618K | Buy |
+3,674
| New | +$618K | 0.27% | 60 |
|
|
2018
Q2 | – | Sell |
-5,100
| Closed | -$770K | – | 73 |
|
|
2018
Q1 | $770K | Buy |
5,100
+150
| +3% | +$22.6K | 0.29% | 57 |
|
|
2017
Q4 | $667K | Sell |
4,950
-13,500
| -73% | -$1.82M | 0.2% | 67 |
|
|
2017
Q3 | $2.7M | Sell |
18,450
-41,150
| -69% | -$6.02M | 0.82% | 43 |
|
|
2017
Q2 | $9.27M | Sell |
59,600
-1,500
| -2% | -$233K | 2.62% | 10 |
|
|
2017
Q1 | $8.87M | Buy |
61,100
+44,700
| +273% | +$6.49M | 2.85% | 9 |
|
|
2016
Q4 | $1.79M | Buy |
+16,400
| New | +$1.79M | 0.74% | 43 |
|
|
2015
Q4 | – | Sell |
-10,500
| Closed | -$1.4M | – | 82 |
|
|
2015
Q3 | $1.4M | Sell |
10,500
-500
| -5% | -$66.4K | 0.47% | 53 |
|
|
2015
Q2 | $1.94M | Buy |
11,000
+300
| +3% | +$52.8K | 0.57% | 50 |
|
|
2015
Q1 | $1.85M | Buy |
+10,700
| New | +$1.85M | 0.61% | 54 |
|